LLY PEER ANALYSIS

Eli Lilly and Company — metric-by-metric comparison with peers and the industry median

LLYEli Lilly and Company

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - General

Position Within Industry

0 = weak quartile, 100 = strong quartile

LLYIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	LLY	SAN	BAYN	AZN	Ind. Median
P/E	43.03	8.81●	—	29.05	23.37
P/B	34.86	1.25●	1.82	6.38	4.60
EV/EBITDA	33.64	9.72●	24.14	16.08	13.81
P/S	15.05	1.97	1.16●	4.99	3.25

Financial Health
Metric	LLY	SAN	BAYN	AZN	Ind. Median
Current Ratio	1.50●	1.01	1.06	0.91	1.25
Debt/Equity	139.0%	27.5%●	134.8%	71.7%	94.3%
NetDebt/EBITDA	1.14●	1.33	9.19	1.29	1.35

Profitability
Metric	LLY	SAN	BAYN	AZN	Ind. Median
Net Margin	35.0%●	22.3%	-4.8%	17.2%	15.0%
ROE	107.6%●	14.1%	-7.0%	23.5%	23.7%
ROA	24.5%●	8.0%	-2.0%	9.4%	8.0%
EBITDA Margin	46.3%●	23.4%	7.7%	33.7%	28.4%

Growth + Dividend
Metric	LLY	SAN	BAYN	AZN	Ind. Median
Rev. Growth	47.4%●	3.3%	-2.9%	9.9%	3.3%
NI Growth	127.6%●	59.8%	—	33.7%	32.9%
Div. Yield	0.5%●	0.0%	0.2%	0.2%	2.1%
Payout	22.1%	0.0%	-5.9%	47.3%	45.7%

Valuation
Metric	LLY	JNJ	ABBV	MRK	AMGN	GILD	Ind. Median
P/E	43.03	30.57	127.27	35.84	26.09	17.86●	23.37
P/B	34.86	7.92	-70.05●	6.98	22.15	7.00	4.60
EV/EBITDA	33.64	20.19	31.12	19.37	14.91	12.22●	13.81
P/S	15.05	6.67	7.37	4.88●	5.47	5.54	3.25

Financial Health
Metric	LLY	JNJ	ABBV	MRK	AMGN	GILD	Ind. Median
Current Ratio	1.50	1.03	0.80	1.30	1.26	1.97●	1.25
Debt/Equity	139.0%	67.7%	-1,101.9%●	107.1%	623.8%	94.3%	94.3%
NetDebt/EBITDA	1.14	0.98	3.75	2.31	2.71	0.85●	1.35

Profitability
Metric	LLY	JNJ	ABBV	MRK	AMGN	GILD	Ind. Median
Net Margin	35.0%●	21.8%	5.8%	13.6%	20.9%	31.0%	15.0%
ROE	107.6%●	26.4%	—	19.0%	101.3%	43.2%	23.7%
ROA	24.5%●	10.7%	2.7%	7.3%	8.6%	16.4%	8.0%
EBITDA Margin	46.3%	34.8%	26.9%	28.6%	44.8%	48.7%●	28.4%

Growth + Dividend
Metric	LLY	JNJ	ABBV	MRK	AMGN	GILD	Ind. Median
Rev. Growth	47.4%●	7.9%	9.5%	2.5%	9.1%	3.5%	3.3%
NI Growth	127.6%●	-3.5%	-13.3%	-48.7%	31.5%	54.5%	32.9%
Div. Yield	0.5%	2.1%	2.7%●	2.6%	2.7%	2.5%	2.1%
Payout	22.1%	59.5%	324.8%	92.1%	66.7%	43.8%	45.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on LLY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.